Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

W Akhtar, MF Khan, G Verma… - European journal of …, 2017‏ - Elsevier
Benzimidazole, a fused heterocycle bearing benzene and imidazole has gained
considerable attention in the field of contemporary medicinal chemistry. The moiety is of …

1, 3, 5-Triazines: A promising scaffold for anticancer drugs development

S Cascioferro, B Parrino, V Spanò, A Carbone… - European journal of …, 2017‏ - Elsevier
This review covering literature reports from the beginning of this century to 2016 describes
the synthetic pathways, the antitumor activity, the structure-activity relationship and …

Recent advances in the biological activity of s-triazine core compounds

D Maliszewski, D Drozdowska - Pharmaceuticals, 2022‏ - mdpi.com
An effective strategy for successful chemotherapy relies on creating compounds with high
selectivity against cancer cells compared to normal cells and relatively low cytotoxicity. One …

Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents

K Haider, S Rehman, A Pathak, AK Najmi… - Archiv der …, 2021‏ - Wiley Online Library
Targeted therapy plays a pivotal role in cancer therapeutics by countering the drawbacks of
conventional treatment like adverse events and drug resistance. Over the last decade …

Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids

M Dinari, F Gharahi, P Asadi - Journal of Molecular Structure, 2018‏ - Elsevier
Abstract A new series of 1, 3, 5-triazine incorporating aromatic quinazolinone moieties as a
potential antimicrobial agents is reported. The first chlorine group of the cyanuric chloride (1) …

Recent insights on synthetic methods and pharmacological potential in relation with structure of benzothiazoles

RK Yadav, R Kumar, H Singh, A Mazumdar… - Medicinal …, 2023‏ - benthamdirect.com
Benzothiazole is a bicyclic heterocyclic compound that contains benzene fused with 1, 3-
thiazole ring. Several researches established the potential of benzothiazoles as important …

IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo

L Guntuku, JK Gangasani, D Thummuri, RM Borkar… - Oncogene, 2019‏ - nature.com
Autophagy is a homeostatic process that recycles damaged organelles and long-lived
proteins by delivering them in double-membrane vesicles to lysosomes for degradation …

Benzimidazole ring system as a privileged template for anticancer agents

A Kanwal, FA Saddique, S Aslam, M Ahmad… - Pharmaceutical …, 2018‏ - Springer
Cancer still remains a continued threat for human race in the 21st century. It is the major
cause of human casualties globally and is thus, a hot topic of research in medicinal …

1, 3, 5-triazine-azole hybrids and their anticancer activity

H Guo, QP Diao - Current Topics in Medicinal Chemistry, 2020‏ - ingentaconnect.com
1, 3, 5-Triazine and azole can interact with various therapeutic targets, and their derivatives
possess promising in vitro and in vivo anticancer activity. Hybrid molecules have the …

Di-and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish …

A El-Faham, M Farooq, Z Almarhoon… - Bioorganic …, 2020‏ - Elsevier
Here we report on a small library based on a 4-aminobenzonitile-s-triazine moiety. We used
a straightforward orthogonal synthetic pathway to prepare di-and tri-substituted s-triazine …